MIAMI, FL / ACCESSWIRE / April 20, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. EBIO, ASM, OCLS, and PBMD have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) a preclinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye. A few weeks ago the company announced financial results for the fourth quarter and full year ended December 31, 2015 and provided a strategic update and review of recent business highlights. Since making the announcement, the company's stock has increased by as much as 129% following highs of $0.94 on Wednesday (4/20).
Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here.
Avino Silver & Gold Mines Ltd. (NYSE MKT: ASM) reported last week its first quarter 2016 production results from its Avino property near Durango, Mexico. These included silver equivalent production increased by 10% to 715,933 oz, silver production increased by 11% to 403,447 oz, and copper production increased by 55% to 1,350,912 Lbs. Shares of ASM have increased by as much as 52% since April 1, after having hit highs on Wednesday morning of $1.50.
Subscribe Now And Reserve A Spot To Receive Our First Alert Of April. Get Your Free Membership Now.
Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) announced it has received a new 510(k) clearance from the FDA for the company's new Microcyn-based Lasercyn Gel. Under the supervision of a healthcare professional, Lasercyn Gel is intended for the management of post-non-ablative laser therapy procedures, post-microdermabrasion therapy and following superficial chemical peels. Following this announcement, prices of OCLS shares jumped more than 40% from the previous close on Tuesday (4/19).
Enjoy picks like this? Get These Alerts and More on NASDAQ Companies before They Rally, Text the word "NASDAQ" to 77948
Prima Biomed Ltd. (NASDAQ: PBMD) has seen an increase in share price of 21% since Monday (4/18). The company's stock hit highs of $1.09 on Wednesday morning with volume also increasing to above average totals. Recently Maxim Group initiated analyst coverage on the company giving it a "Buy" rating. Other Analysts covering the stock include ROTH Capital and H.C. Wainwright.
Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here.
About TopNasdaqStocks.com
Looking for stock market and business news headlines? How about up to the minute information on mutual funds and ETFs? Don't forget about the top stock picks of 2016. TopNasdaqStocks.com has it all. Make sure to subscribe to our free newsletter and to receive free text message alerts on your phone, text "NASDAQ" to 77948.
Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor's or other person's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. Top Nasdaq Stocks has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding EBIO, ASM, OCLS, or PBMD in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words "anticipate," "intend," "estimate," "believe," "expect," "plans," "should," "potential," "forecast," and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company's actual results could differ materially from those described in any forward-looking statements contained herein. Top Nasdaq Stocks is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit http://topnasdaqstocks.com/index.php/disclaimer/ website for a more detailed discussion of risks and disclosures.
Contact:
Top Nasdaq Stocks
news@topnasdaqstocks.com
SOURCE: Top Nasdaq Stocks
ReleaseID: 439044
